Soliton found using ticker (SOLY) now have 3 analysts in total covering the stock. The consensus rating is ‘Buy’. The range between the high target price and low target price is between 22 and 12 with a mean TP of 16. With the stocks previous close at 8.37 this is indicating there is a potential upside of 91.2%. The day 50 moving average is 8.4 and the 200 day MA is 8.22. The company has a market cap of $177m. You can visit the company’s website by visiting: http://www.soliton.com
The potential market cap would be $338m based on the market concensus.
Soliton, a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers product for the removal of tattoos. It also develops product for cellulite reduction, fibrotic scar treatment, and other indications. The company was founded in 2012 and is based in Houston, Texas.
